ArticleBMJ open2025

Brolucizumab efficacy and safety single-arm descriptive trial in patients with persistent diabetic macular edema (BEST study): protocol for a single-centre, open-label, single-arm clinical trial in China.

Ziyi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.